JPRN-jRCT2080225242已完成1 期
Phase 1 Study of DS-3201b to Assess the Effects of Multiple Oral Administration of Rifampicin on the Pharmacokinetics of Single Oral Administration of DS-3201b Tablets in Healthy Japanese Subjects
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 45age old（—）
- 性别
- All
入选标准
- •1. Gender: Japanese males or females
- •2. Age: >=20 and =<45 years (at the time of informed consent)
- •3. Body mass index (BMI) = Body weight (kg) / (Height [m])2: >=18.5 and <25.0 (at screening)
排除标准
- •1. Having a history of hypersensitivity to any drugs or substances including rifampicin, or being idiosyncratic (eg, having penicillin allergy)
- •2. Having alcohol or drug dependence etc.
研究者
相似试验
未知
1 期
Phase 1 study of DS-3201b to assess the effects of itraconazole and fluconazole on the pharmacokinetics of single oral administration of DS-3201b tablets in healthy Japanese subjectsJPRN-jRCT2080223846DAIICHI SANKYO CO., LTD.32
已完成
1 期
Phase 1 study of DS-3201b to evaluate the effect of food (low-fat meal) on the pharmacokinetics in healthy subjectsHealthy subjectsJPRN-jRCT2071200043agao Kiminori28
已完成
1 期
A phase 1 Multiple Ascending Dose Study of DS-3201b in Subjects with LymphomasRelapsed non-hodgkin lymphomaJPRN-jRCT2080223118DAIICHI SANKYO CO., LTD.100
进行中（未招募）
不适用
Pilot study of dMD-002 in patients with neurovascular bundles injury during radical prostatectomyProstate cancerJPRN-jRCT2022210040akamura Masaki12
招募中
2 期
Phase IIa Study to Characterize the Effects of the Spiegelmer® NOX H94 on Anemia of Chronic Disease in Patients With Multiple Myeloma or LymphomaD63.0Anaemia in neoplastic diseaseAnemia of Chronic DiseaseDRKS00004366OXXON Pharma AG48